Volume 9.34 | Sep 9

Neural Cell News 9.34 September 9, 2015
Neural Cell News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook   NCN on Twitter
 
TOP STORY
Image-Tracking Technology Allows Scientists to Observe Nature vs. Nurture in Neural Stem Cells
Researchers present video evidence to support their discovery of distinct, intrinsic differences among stem cells found in the brains of mice. Through time-lapse imaging of cells cultured in identical in vitro environments, researchers were able to identify differences in growth, movement and differentiation that exist between stem cells found in two different areas of the brain. [Press release from Drexel University discussing online publication in Stem Cell Reports] Press Release | Full Article | Video
Register for the Webinar “From Pluripotent Stem Cells to Neurons and Astrocytes - Modeling Human Neurological Disease”
 
PUBLICATIONS (Ranked by impact factor of the journal)
GGGGCC Repeat Expansion in C9orf72 Compromises Nucleocytoplasmic Transport
Scientists found morphological abnormalities in the architecture of the nuclear envelope in cells expressing expanded GGGGCC G4C2 repeats in vitro and in vivo. They identified a substantial defect in RNA export resulting in retention of RNA in the nuclei of Drosophila cells expressing expanded G4C2 repeats and also in mammalian cells, including aged induced pluripotent stem-cell-derived neurons from patients with C9orf72-related disease. [Nature] Abstract

The C9orf72 Repeat Expansion Disrupts Nucleocytoplasmic Transport
RanGAP physically interacts with hexanucleotide repeat expansion (HRE) RNA and is mislocalized in HRE-expressing flies, neurons from C9orf72 amyotrophic lateral sclerosis (ALS) patient-derived induced pluripotent stem cells, and in C9orf72 ALS patient brain tissue. [Nature] Abstract

Modifiers of C9orf72 Dipeptide Repeat Toxicity Connect Nucleocytoplasmic Transport Defects to FTD/ALS
Dipeptide repeat proteins produced by unconventional translation of the C9orf72 repeat expansions caused neurodegeneration in cell culture and in animal models. [Nat Neurosci] Abstract | Press Release

Altered Neuronal Network and Rescue in a Human MECP2 Duplication Model
The authors generated induced pluripotent stem cells from patients with the methyl-CpG-binding protein-2 (MECP2) duplication syndrome, carrying different duplication sizes, to study the impact of increased MeCP2 dosage in human neurons. [Mol Psych] Abstract | Press Release

The Myelin Oligodendrocyte Glycoprotein Directly Binds Nerve Growth Factor to Modulate Central Axon Circuitry
The authors identified nerve growth factor (NGF) as a binding partner for myelin oligodendrocyte glycoprotein and demonstrated that this interaction is capable of sequestering NGF from TrkA-expressing neurons to modulate axon growth and survival. [J Cell Biol] Abstract

Transcription Factors Sox5 and Sox6 Exert Direct and Indirect Influences on Oligodendroglial Migration in Spinal Cord and Forebrain
Using mice with specific deletion of the SoxD proteins Sox5 and Sox6 in the central nervous system, scientists showed that SoxD proteins additionally influence migration of oligodendrocyte progenitors in the spinal cord as well as in the forebrain. [Glia] Abstract

A Septo-Temporal Molecular Gradient of sfrp3 in the Dentate Gyrus Differentially Regulates Quiescent Adult Hippocampal Neural Stem Cell Activation
Scientists showed that activation rates within the quiescent radial glia-like neural stem cell (RGL) population decrease gradually along the septo-temporal axis in the adult mouse dentate gyrus, as defined by MCM2 expression in RGLs. [Mol Brain] Full Article

Subventricular Zone Neural Progenitors Reverse TNF-Alpha Effects in Cortical Neurons
Investigators demonstrated that adult neural stem cells (aNPCs) from the subventricular zone reverse the effects induced by the cytokine. Moreover, they showed that the effect of aNPCs on cortical neurons is mediated by cannabinoid CB1 receptor activation. [Stem Cell Res Ther] Full Article

Agmatine Protects Against 6-OHDA-Induced Apoptosis, and ERK and Akt/GSK Disruption in SH-SY5Y Cells
Scientists assessed whether agmatine prevents 6-hydroxydopamine (6-OHDA)-induced SH-SY5Y cell death and if so, then how it affects Akt/glycogen synthesis kinase(GSK)-3β and extracellular signal-regulated kinases (ERK) signals. [Cell Mol Neurobiol] Abstract

Indirubin-3-Oxime Effectively Prevents 6OHDA-Induced Neurotoxicity in PC12 Cells via Activating MEF2D through the Inhibition of GSK3β
Researchers showed that indirubin-3-oxime prevented 6-hydroxydopamine (6OHDA)-induced neuronal apoptosis and intracellular reactive oxygen species accumulation in PC12 cells in a concentration-dependent manner. [J Mol Neurosci] Abstract

Free Wallchart from Nature Reviews Neuroscience on Modeling Neurological Disease with iPS Cells
 
REVIEWS
Neurons and T Cells: Understanding this Interaction for Inflammatory Neurological Diseases
The authors discuss the processes by which T cells mediate either beneficial or deleterious effects within the central nervous system, with emphasis on the direct interaction between T cells and neurons, as occurs in multiple sclerosis, paraneoplastic cerebellar degeneration, and viral encephalitis. The therapeutic approaches targeting T cells and their mediators as treatment for neurological diseases are also described. [Eur J Immunol] Abstract

Development of Stem Cell-Based Therapy for Parkinson’s Disease
The authors evaluate the research progress in different cell sources with a focus on using induced pluripotent stem cells as a valuable source and propose key challenges for developing cells suitable for large-scale clinical applications in the treatment of Parkinson’s disease. [Transl Neurodegener] Full Article

Visit our reviews page to see a complete list of reviews in the neural cell research field.
 
INDUSTRY NEWS
Biogen Enrolls First Patient in Global Phase III Study of Investigational Treatment Aducanumab (BIIB037) for Early Alzheimer’s Disease
Biogen announced that the first patient has been enrolled in the Phase III clinical program for its investigational treatment aducanumab. The Phase III program includes two global, placebo-controlled studies named ENGAGE and EMERGE, which are designed to evaluate the efficacy and safety of aducanumab in slowing cognitive impairment and the progression of disability in people with early Alzheimer’s disease. [Biogen] Press Release

Johns Hopkins University, Cedars-Sinai and Massachusetts General Hospital Announce Groundbreaking ALS Research Project of Answer ALS
Johns Hopkins University’s Robert Packard Center for ALS Research, Cedars-Sinai Medical Center’s Regenerative Medicine Institute and the Massachusetts General Hospital Neurological Clinical Research Institute announced the launch of an Amyotrophic Lateral Sclerosis (ALS) research project of Answer ALS, the largest single coordinated and comprehensive effort to end ALS. [Johns Hopkins University (Business Wire)] Press Release

Celsion Completes Integration of EGEN and Outlines Clinical Development Plan for GEN-1 IL-12 Immunotherapy Program
Celsion Corporation announced that the company has completed the integration of its June 2014 acquisition of EGEN, Inc. and has provided an update on its clinical development plans for GEN-1, the company’s DNA-based immunotherapy for the localized treatment of ovarian and brain cancer. [Celsion Corporation] Press Release

Mayo Clinic and Hootsuite Introduce Social Media Training Program for Health Care
Hootsuite and Mayo Clinic Center for Social Media, announced an industry-leading social media credential for medical and health care professionals. [Hootsuite Media Inc.] Press Release

From our sponsor:
Interested in assays for human mammary stem and progenitor cells?
Request your free wallchart.
 
POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW Keystone Symposia: Axons – From Cell Biology to Pathology
January 24-27, 2016
Santa Fe, United States

NEW Keystone Symposia: Stem Cells and Regeneration in the Digestive Organs
March 13-17, 2016
Keystone, United States

Visit our events page to see a complete list of events in the neural cell community.
 
JOB OPPORTUNITIES
NEW Postdoctoral Position – Brain Tumor Research (Research Institute of the McGill University Health Centre)

Postdoctoral Position – Spinal Cord Injury Research (Indiana University-Purdue University)

Postdoctoral Position – Neuroimmunology (Brain and Spine Institute)

Director – Duke Institute for Brain Sciences (Duke University)

Postdoctoral Research Fellow – Glioblastoma Stem-Like Cells and Non-Neoplastic Neural Stem Cells (Fred Hutchinson Cancer Research Center)

Harry Eagle Scholar Awards for Postdoctoral Candidates (Albert Einstein College of Medicine of Yeshiva University)

Postdoctoral Positions – Cancer Research (Rutgers University)

PhD Student – Biology of Brain Metastasis (Centro Nacional de Investigaciones Oncológicas)


Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Neural Cell News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Neural Cell News: Archives | Events | Contact Us